1. 16P Neutrophil-lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors. (15th December 2019) Authors: Murthy, N Y; Rauthan, A; Patil, P; Somashekhar, S P; Zaveri, S; Lahkar, K; Gupta, K; Nigade, G R; Sood, T; Kulkarni, S S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 212PImmunotherapy with nivolumab in metastatic renal cell carcinoma patients in India: Bringing a change in clinical practice. (24th November 2019) Authors: Rauthan, A; Patil, P; Prasannakumar, S Sampige; Zaveri, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 234PSurvival outcomes of dose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Indian scenario. (23rd October 2018) Authors: Sood, T; Rauthan, A; Patil, P; Kulkarni, S; Somashekhar, S P; Zaveri, S; Ahuja, V; Ashwin, K R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 25 CRS with hipec in advanced epithelial ovarian cancer with comparison of oncological outcome only with CRS + intravenous chemotherapy and CRS plus normothermic intra-peritoneal chemotherapy. (18th September 2019) Authors: Somashekar, S; Rohit Kumar, C; Ashwin, K; Zaveri, S; Ahuja, VK; Rauthan, A; Ramya, Y Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 269 A prospective study of factors predicting morbidity and mortality in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian malignancy. (18th September 2019) Authors: Ahuja, VK; Somashekar, S; Ashwin, K; Zaveri, S; Rohit Kumar, C; Rauthan, A; Ramya, Y Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 334 A prospective non-randomized study comparing the outcomes following complete versus selective parietal peritonectomy during CRS+HIPEC for advanced epithelial ovarian cancer. (18th September 2019) Authors: Somashekar, S; Rohit Kumar, C; Ashwin, K; Zaveri, S; Ahuja, VK; Rauthan, A; Ramya, Y Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 362 Double arm study of performing bowel anastomosis after or before hipec in patients undergoing CRS+ HIPEC for advanced epithelial ovarian cancer. (13th November 2020) Authors: Somashekar, S; Ashwin, K; Ramya, Y; Zaveri, S; Ahuja, V; Rohit Kumar, C Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 391PMismatch repair deficiency testing for immunotherapy in metastatic cancers: A single centre study from India. (25th November 2018) Authors: Sood, T; Rauthan, A; Patil, P; Kulkarni, S S; Somashekhar, S P; Zaveri, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 508POncogenic driver mutation analysis in lung adenocarcinoma: A single center study in India. (25th November 2018) Authors: Kulkarni, S S; Rauthan, A; Patil, P; Sood, T; Somashekhar, S; Zaveri, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 84PReal world experience of adverse events with immunotherapy using PD1 inhibitors: Single center experience from India. (25th November 2018) Authors: Rauthan, A; Patil, P; Somashekhar, S P; Zaveri, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗